Gary Robb appointed to get Corcept finance fit
This article was originally published in Scrip
Corcept Therapeutics has appointed Gary Robb, previously senior vice-president of operations, administration and finance at Fitness Anywhere, CFO effective 1 September. While at Fitness Anywhere, a private fitness equipment and training company, Mr Robb's responsibilities included finance, legal affairs, HR and distribution and logistics, among others.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.